Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol

Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol

Abstract Background Improved risk stratification, more effective therapy and better supportive care have resulted in survival rates after childhood cancer of around 80% in developed countries. Treatment however can be harsh, and three in every four childhood cancer survivors (CCS) develop at least o...

Full description

Bibliographic Details
Main Authors: Anne-Lotte L. F. van der Kooi, Eva Clemens, Linda Broer, Oliver Zolk, Julianne Byrne, Helen Campbell, Marleen van den Berg, Claire Berger, Gabriele Calaminus, Uta Dirksen, Jeanette Falck Winther, Sophie D Fosså, Desiree Grabow, Riccardo Haupt, Melanie Kaiser, Tomas Kepak, Leontien Kremer, Jarmila Kruseova, Dalit Modan-Moses, Andreas Ranft, Claudia Spix, Peter Kaatsch, Joop S. E. Laven, Eline van Dulmen-den Broeder, André G. Uitterlinden, Marry M. van den Heuvel-Eibrink, on behalf of the PanCareLIFE Consortium
Format: Article
Language:English
Published: BMC 2018-09-01
Series:BMC Cancer
Subjects:
Childhood cancer survivor
Genetic variations
SNPs
Late effects
GWAS
Online Access:http://link.springer.com/article/10.1186/s12885-018-4834-3

Internet

http://link.springer.com/article/10.1186/s12885-018-4834-3

Similar Items